A detailed history of Abbrea Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Abbrea Capital, LLC holds 5,640 shares of DHR stock, worth $1.37 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
5,640
Previous 5,768 2.22%
Holding current value
$1.37 Million
Previous $1.44 Million 2.15%
% of portfolio
0.19%
Previous 0.19%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$235.51 - $267.98 $30,145 - $34,301
-128 Reduced 2.22%
5,640 $1.41 Million
Q1 2024

May 07, 2024

BUY
$224.58 - $256.19 $11,453 - $13,065
51 Added 0.89%
5,768 $1.44 Million
Q4 2023

Feb 02, 2024

SELL
$185.1 - $233.13 $18,510 - $23,313
-100 Reduced 1.72%
5,717 $1.32 Million
Q3 2023

Oct 31, 2023

SELL
$233.08 - $265.59 $23,308 - $26,558
-100 Reduced 1.69%
5,817 $1.44 Million
Q2 2023

Aug 01, 2023

BUY
$224.99 - $256.14 $17,099 - $19,466
76 Added 1.3%
5,917 $1.42 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $11,987 - $13,850
50 Added 0.86%
5,841 $1.47 Million
Q4 2022

Feb 08, 2023

SELL
$241.42 - $282.29 $15,209 - $17,784
-63 Reduced 1.08%
5,791 $1.54 Million
Q3 2022

Nov 03, 2022

BUY
$247.06 - $1507.4 $8,400 - $51,251
34 Added 0.58%
5,854 $1.51 Million
Q2 2022

Aug 02, 2022

SELL
$237.11 - $299.66 $4,742 - $5,993
-20 Reduced 0.34%
5,820 $1.48 Million
Q1 2022

May 11, 2022

BUY
$257.27 - $315.76 $9,004 - $11,051
35 Added 0.6%
5,840 $1.72 Million
Q4 2021

Feb 04, 2022

BUY
$292.08 - $329.01 $167,946 - $189,180
575 Added 10.99%
5,805 $1.91 Million
Q3 2021

Nov 04, 2021

BUY
$272.21 - $332.43 $98,812 - $120,672
363 Added 7.46%
5,230 $1.59 Million
Q2 2021

Aug 04, 2021

BUY
$225.08 - $271.69 $64,147 - $77,431
285 Added 6.22%
4,867 $1.31 Million
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $55,431 - $64,179
261 Added 6.04%
4,582 $1.03 Million
Q4 2020

Jan 21, 2021

BUY
$212.5 - $245.46 $10,412 - $12,027
49 Added 1.15%
4,321 $961,000
Q3 2020

Oct 20, 2020

BUY
$177.16 - $215.33 $46,770 - $56,847
264 Added 6.59%
4,272 $921,000
Q2 2020

Aug 11, 2020

SELL
$128.7 - $176.83 $23,423 - $32,183
-182 Reduced 4.34%
4,008 $709,000
Q1 2020

Apr 29, 2020

BUY
$121.39 - $169.05 $7,647 - $10,650
63 Added 1.53%
4,190 $581,000
Q4 2019

Feb 11, 2020

BUY
$133.47 - $153.48 $30,698 - $35,300
230 Added 5.9%
4,127 $634,000
Q3 2019

Nov 07, 2019

BUY
$135.4 - $146.47 $76,501 - $82,755
565 Added 16.96%
3,897 $564,000
Q2 2019

Jul 31, 2019

BUY
$124.88 - $143.73 $44,207 - $50,880
354 Added 11.89%
3,332 $477,000
Q1 2019

May 08, 2019

BUY
$97.62 - $132.29 $19,524 - $26,458
200 Added 7.2%
2,978 $394,000
Q4 2018

Feb 05, 2019

BUY
$94.85 - $109.54 $11,382 - $13,144
120 Added 4.51%
2,778 $287,000
Q2 2018

Aug 08, 2018

BUY
$96.1 - $103.24 $255,433 - $274,411
2,658 New
2,658 $263,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.